Semaglutide

12 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

Semaglutide
Treatment and conditionWhere it standsTrials
Semaglutide for alcoholismPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)6
Semaglutide for atherosclerosisPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Semaglutide for atrial fibrillationPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Semaglutide for diabetes mellitusPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Semaglutide for diabetes mellitus, type 2Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person)7
Semaglutide for glucose intolerancePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Semaglutide for non-alcoholic fatty liver diseasePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
Semaglutide for obesityPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)20
Semaglutide for pediatric obesityPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Semaglutide for prediabetic statePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)3
Semaglutide for pulmonary disease, chronic obstructivePhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Semaglutide for renal insufficiency, chronicPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2